Authors: Saracco, G Ciancio, A Ghisetti, V Rocca, G Cariti, G Andreoni, M Tabone, M Roffi, L Calleri, G Ballare, M Terreni, N Sartori, M Tappero, GF Traverso, A Poggio, A Orani, A Maggi, G Di Napoli, A Arrigoni, A Rizzetto, M

Citation: G. Saracco et al., Treatment with interferon-alpha 2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study, EUR J GASTR, 13(2), 2001, pp. 149-155

Authors: Rezza, G Lepri, AC Monforte, AD Pezzotti, P Castelli, F Dianzani, F Lazzarin, A De Luca, A Arlotti, M Leoncini, F Manconi, PE Rizzardini, G Minoli, L Poggio, A Ippolito, G Phillips, AN Moroni, M

Citation: G. Rezza et al., Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection, J ACQ IMM D, 25(1), 2000, pp. 56-62

Authors: Saracco, G Sostegni, R Ghisetti, V Rocca, G Cariti, G Andreoni, M Tabone, M Roffi, L Calleri, G Ballare, M Minoli, G Sartori, M Tappero, GF Traverso, A Poggio, A Orani, A Maggi, G Rizzetto, M

Citation: G. Saracco et al., Hepatitis C virus genotypes in a non-cirrhotic Italian population with chronic hepatitis C: correlation with clinical, virological and histological parameters. Results of a prospective multicentre study, J VIRAL HEP, 7(2), 2000, pp. 124-129

Authors: Torre, D Zeroli, C Ferrario, G Pugliese, A Speranza, F Orani, A Casari, S Bassi, P Poggio, A Carosi, GP Fiori, GP

Citation: D. Torre et al., Levels of nitric oxide, gamma interferon and interleukin-12 in AIDS patients with toxoplasmic encephalitis, INFECTION, 27(3), 1999, pp. 218-220